Literature DB >> 3804327

Deficiency of AMP deaminase in erythrocytes.

N Ogasawara, H Goto, Y Yamada, I Nishigaki, T Itoh, I Hasegawa, K S Park.   

Abstract

Six individuals with complete deficiency of erythrocyte AMP deaminase have been discovered. They are all healthy and have no hematological disorders. The deficiency is only in isozyme E, which is the erythrocyte type isozyme, and is inherited as an autosomal recessive trait. The frequency of the mutant gene is surprisingly high, one heterozygote in about 30 of the population in Japan, Seoul, and Taipei. The ATP level is approximately 50% higher in AMP-deficient erythrocytes compared to that of control cells. Degradation of adenine nucleotide is slower in the deficient erythrocytes than in the control erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3804327     DOI: 10.1007/bf00273831

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  REGULATION OF ADENYLATE DEAMINASE BY ADENOSINE TRIPHOSPHATE.

Authors:  B CUNNINGHAM; J M LOWENSTEIN
Journal:  Biochim Biophys Acta       Date:  1965-03-22

2.  The purine nucleotide cycle. Control of phosphofructokinase and glycolytic oscillations in muscle extracts.

Authors:  K Tornheim; J M Lowenstein
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

3.  Purine nucleotide cycle. Evidence for the occurrence of the cycle in brain.

Authors:  V Schultz; J M Lowenstein
Journal:  J Biol Chem       Date:  1976-01-25       Impact factor: 5.157

4.  Distribution of AMP deaminase isozymes in various human blood cells.

Authors:  N Ogasawara; H Goto; Y Yamada; T Watanabe
Journal:  Int J Biochem       Date:  1984

5.  AMP deaminase isozymes in human tissues.

Authors:  N Ogasawara; H Goto; Y Yamada; T Watanabe; T Asano
Journal:  Biochim Biophys Acta       Date:  1982-02-02

6.  Ammonia production in muscle: the purine nucleotide cycle.

Authors:  J Lowenstein; K Tornheim
Journal:  Science       Date:  1971-01-29       Impact factor: 47.728

7.  The purine nucleotide cycle. A pathway for ammonia production in the rat kidney.

Authors:  R T Bogusky; L M Lowenstein; J M Lowenstein
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

8.  Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.

Authors:  R L Sabina; J L Swain; C W Olanow; W G Bradley; W N Fishbein; S DiMauro; E W Holmes
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

9.  Rat muscle 5'-adenylic acid aminohydrolase. Role of K+ and adenylate energy charge in expression of kinetic and regulatory properties.

Authors:  C J Coffee; C Solano
Journal:  J Biol Chem       Date:  1977-03-10       Impact factor: 5.157

10.  Adenosine kinase from human liver.

Authors:  Y Yamada; H Goto; N Ogasawara
Journal:  Biochim Biophys Acta       Date:  1981-07-24
View more
  9 in total

1.  A novel pathway for alternative splicing: identification of an RNA intermediate that generates an alternative 5' splice donor site not present in the primary transcript of AMPD1.

Authors:  I Mineo; P R Clarke; R L Sabina; E W Holmes
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 2.  Molecular biology of AMP deaminase deficiency.

Authors:  M Gross
Journal:  Pharm World Sci       Date:  1994-04-15

3.  Comparative enzymology of AMP deaminase, adenylate kinase, and creatine kinase in vertebrate heart and skeletal muscle: the characteristic AMP deaminase levels of skeletal versus cardiac muscle are reversed in the North American toad.

Authors:  W N Fishbein; J I Davis; J W Foellmer
Journal:  J Comp Physiol B       Date:  1993       Impact factor: 2.200

4.  AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder.

Authors:  Naiara Akizu; Vincent Cantagrel; Jana Schroth; Na Cai; Keith Vaux; Douglas McCloskey; Robert K Naviaux; Jeremy Van Vleet; Ali G Fenstermaker; Jennifer L Silhavy; Judith S Scheliga; Keiko Toyama; Hiroko Morisaki; Fatma M Sonmez; Figen Celep; Azza Oraby; Maha S Zaki; Raidah Al-Baradie; Eissa A Faqeih; Mohammed A M Saleh; Emily Spencer; Rasim Ozgur Rosti; Eric Scott; Elizabeth Nickerson; Stacey Gabriel; Takayuki Morisaki; Edward W Holmes; Joseph G Gleeson
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

5.  Inborn errors of purine metabolism: clinical update and therapies.

Authors:  Shanti Balasubramaniam; John A Duley; John Christodoulou
Journal:  J Inherit Metab Dis       Date:  2014-06-28       Impact factor: 4.982

6.  Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP.

Authors:  Todd A Johnson; H A Jinnah; Naoyuki Kamatani
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

7.  Adenosine monophosphate deaminase 3 null mutation causes reduction of naive T cells in mouse peripheral blood.

Authors:  Xiaoming Zhan; Xue Zhong; Jin Huk Choi; Lijing Su; Jianhui Wang; Evan Nair-Gill; Priscilla Anderton; Xiaohong Li; Miao Tang; Jamie Russell; Sara Ludwig; Thomas Gallagher; Bruce Beutler
Journal:  Blood Adv       Date:  2020-08-11

8.  AMP deaminase 3 deficiency enhanced 5'-AMP induction of hypometabolism.

Authors:  Isadora Susan Daniels; William G O Brien; Vinay Nath; Zhaoyang Zhao; Cheng Chi Lee
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

9.  CD73 and AMPD3 deficiency enhance metabolic performance via erythrocyte ATP that decreases hemoglobin oxygen affinity.

Authors:  William G O'Brien; Vladimir Berka; Ah-Lim Tsai; Zhaoyang Zhao; Cheng Chi Lee
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.